{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:01:15Z","timestamp":1790812875463,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T00:00:00Z","timestamp":1569628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"DOD PCRP","doi-asserted-by":"publisher","award":["W81XWH-16-1-0404"],"award-info":[{"award-number":["W81XWH-16-1-0404"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA166440"],"award-info":[{"award-number":["CA166440"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Urology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ajur.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T11:22:08Z","timestamp":1570188128000},"page":"219-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Androgen receptor co-regulation in prostate cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Dhirodatta","family":"Senapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore V.","family":"Heemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajur.2019.09.005_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajur.2019.09.005_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030452","article-title":"Androgen signaling in prostate cancer","volume":"7","author":"Dai","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ajur.2019.09.005_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrc801","article-title":"A history of prostate cancer treatment","volume":"2","author":"Denmeade","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajur.2019.09.005_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tem.2010.01.002","article-title":"Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer","volume":"21","author":"Knudsen","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajur.2019.09.005_bib5","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1158\/1078-0432.CCR-08-2660","article-title":"Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer","volume":"15","author":"Knudsen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajur.2019.09.005_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajur.2019.09.005_bib7","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1715546","article-title":"Apalutamide treatment and metastasis-free survival in prostate cancer","volume":"378","author":"Smith","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajur.2019.09.005_bib8","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO.2018.77.9827","article-title":"Abiraterone alone or in combination with enzalutamide in metastatic castration-resistant prostate cancer with rising prostate-specific antigen during enzalutamide treatment","volume":"36","author":"Attard","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajur.2019.09.005_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrurol.2018.22","article-title":"Cellular plasticity and the neuroendocrine phenotype in prostate cancer","volume":"15","author":"Davies","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ajur.2019.09.005_bib10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccr.2010.04.027","article-title":"Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor","volume":"17","author":"Andersen","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajur.2019.09.005_bib11","doi-asserted-by":"crossref","first-page":"26417","DOI":"10.1074\/jbc.M114.553818","article-title":"Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer","volume":"289","author":"Dalal","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajur.2019.09.005_bib12","doi-asserted-by":"crossref","first-page":"R275","DOI":"10.1530\/ERC-17-0121","article-title":"Rationale for the development of alternative forms of androgen deprivation therapy","volume":"24","author":"Kumari","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ajur.2019.09.005_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajur.2018.07.003","article-title":"Current strategies for targeting the activity of androgen receptor variants","volume":"6","author":"Armstrong","year":"2019","journal-title":"Asian J Urol"},{"key":"10.1016\/j.ajur.2019.09.005_bib14","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/1535-7163.MCT-16-0912","article-title":"Niclosamide and bicalutamide combination treatment overcomes enzalutamide- and bicalutamide-resistant prostate cancer","volume":"16","author":"Liu","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ajur.2019.09.005_bib15","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1210\/er.2007-0019","article-title":"Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex","volume":"28","author":"Heemers","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajur.2019.09.005_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/er.2002-0032","article-title":"Androgen receptor in prostate cancer","volume":"25","author":"Heinlein","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajur.2019.09.005_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0303-7207(92)90004-P","article-title":"Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene","volume":"88","author":"Deslypere","year":"1992","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajur.2019.09.005_bib18","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1016\/S0021-9258(17)33103-4","article-title":"Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate","volume":"251","author":"Wilson","year":"1976","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajur.2019.09.005_bib19","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.1158\/0008-5472.CAN-07-5997","article-title":"Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer","volume":"68","author":"Locke","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajur.2019.09.005_bib20","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1021\/tx030011g","article-title":"Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor","volume":"16","author":"Fang","year":"2003","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.ajur.2019.09.005_bib21","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1158\/0008-5472.CAN-11-0532","article-title":"Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors","volume":"71","author":"Cai","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajur.2019.09.005_bib22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","article-title":"Development of a second-generation antiandrogen for treatment of advanced prostate cancer","volume":"324","author":"Tran","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ajur.2019.09.005_bib23","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1172\/JCI87328","article-title":"Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer","volume":"127","author":"Norris","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ajur.2019.09.005_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature17954","article-title":"Redirecting abiraterone metabolism to fine-tune prostate cancer anti-androgen therapy","volume":"533","author":"Li","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ajur.2019.09.005_bib25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2019.09.005_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/er.2015-1034","article-title":"Determinants of receptor- and tissue-specific actions in androgen signaling","volume":"36","author":"Pihlajamaa","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajur.2019.09.005_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsbmb.2016.04.007","article-title":"A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice","volume":"163","author":"Chisamore","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.ajur.2019.09.005_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"Electronic address scmo, cancer genome atlas research N. The molecular taxonomy of primary prostate cancer","volume":"163","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ajur.2019.09.005_bib29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nm.4053","article-title":"Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer","volume":"22","author":"Kumar","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.ajur.2019.09.005_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrurol.2017.201","article-title":"HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer","volume":"15","author":"Hettel","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.ajur.2019.09.005_bib31","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1158\/0008-5472.CAN-12-1335","article-title":"Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors","volume":"72","author":"Mitsiades","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajur.2019.09.005_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ajur.2019.09.005_bib33","article-title":"Regulators of Androgen Action Resource: a one-stop shop for the comprehensive study of androgen receptor action","volume":"2016:bav125","author":"DePriest","year":"2016","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.ajur.2019.09.005_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccell.2019.01.008","article-title":"ARv7 represses tumor-suppressor genes in castration-resistant prostate cancer","volume":"35","author":"Cato","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajur.2019.09.005_bib35","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molcel.2007.05.041","article-title":"A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth","volume":"27","author":"Wang","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajur.2019.09.005_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cell.2009.04.056","article-title":"Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ajur.2019.09.005_bib37","doi-asserted-by":"crossref","first-page":"502","DOI":"10.15252\/embj.201490306","article-title":"Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer","volume":"34","author":"Chen","year":"2015","journal-title":"EMBO J"},{"key":"10.1016\/j.ajur.2019.09.005_bib38","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1073\/pnas.1718811115","article-title":"Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajur.2019.09.005_bib39","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1038\/emboj.2011.158","article-title":"The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis","volume":"30","author":"Massie","year":"2011","journal-title":"EMBO J"},{"key":"10.1016\/j.ajur.2019.09.005_bib40","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1093\/nar\/gkv262","article-title":"Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies","volume":"43","author":"Chan","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajur.2019.09.005_bib41","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/onc.2016.334","article-title":"Cell cycle-coupled expansion of AR activity promotes cancer progression","volume":"36","author":"McNair","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ajur.2019.09.005_bib42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.eururo.2017.11.038","article-title":"Role of androgen receptor variants in prostate cancer: report from the 2017 mission androgen receptor variants meeting","volume":"73","author":"Luo","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2019.09.005_bib43","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/ng.3419","article-title":"The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis","volume":"47","author":"Pomerantz","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajur.2019.09.005_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2012.11.010","article-title":"The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man","volume":"23","author":"Sharma","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajur.2019.09.005_bib45","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1038\/s41467-018-07270-2","article-title":"Integrative epigenetic taxonomy of primary prostate cancer","volume":"9","author":"Stelloo","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajur.2019.09.005_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/humu.22909","article-title":"Putative prostate cancer risk SNP in an androgen receptor-binding site of the melanophilin gene illustrates enrichment of risk SNPs in androgen receptor target sites","volume":"37","author":"Bu","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajur.2019.09.005_bib47","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1038\/s41467-018-04109-8","article-title":"Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants","volume":"9","author":"Dadaev","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajur.2019.09.005_bib48","doi-asserted-by":"crossref","first-page":"30605","DOI":"10.1074\/jbc.M304582200","article-title":"Differential requirement of SWI\/SNF for androgen receptor activity","volume":"278","author":"Marshall","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajur.2019.09.005_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1210\/me.2006-0269","article-title":"Proline-, glutamic acid-, and leucine-rich protein-1\/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2","volume":"21","author":"Nair","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajur.2019.09.005_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1083\/jcb.200503106","article-title":"Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors","volume":"170","author":"Mills","year":"2005","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ajur.2019.09.005_bib51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1677\/jme.1.01991","article-title":"Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland","volume":"36","author":"Gao","year":"2006","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.ajur.2019.09.005_bib52","doi-asserted-by":"crossref","first-page":"e28482","DOI":"10.7554\/eLife.28482","article-title":"A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer","volume":"6","author":"Liu","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ajur.2019.09.005_bib53","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/celldisc.2016.41","article-title":"NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR\/FOXA1 signaling axis","volume":"2","author":"Jeter","year":"2016","journal-title":"Cell Discov"},{"key":"10.1016\/j.ajur.2019.09.005_bib54","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jcp.25099","article-title":"Androgen receptor coactivators in regulation of growth and differentiation in prostate cancer","volume":"231","author":"Culig","year":"2016","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajur.2019.09.005_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajur.2019.09.005_bib56","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ng.2279","article-title":"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer","volume":"44","author":"Barbieri","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajur.2019.09.005_bib57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0303-7207(02)00368-4","article-title":"Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency","volume":"198","author":"Imperato-McGinley","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajur.2019.09.005_bib58","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJM199505253322101","article-title":"Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer","volume":"332","author":"Taplin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajur.2019.09.005_bib59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2013.09.009","article-title":"Looking at nuclear receptors from a new angle","volume":"382","author":"Helsen","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajur.2019.09.005_bib60","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chembiol.2009.01.016","article-title":"Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands","volume":"16","author":"Norris","year":"2009","journal-title":"Chem Biol"},{"key":"10.1016\/j.ajur.2019.09.005_bib61","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1210\/me.2005-0309","article-title":"Linking ligand-induced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators","volume":"20","author":"Kazmin","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajur.2019.09.005_bib62","doi-asserted-by":"crossref","first-page":"12298","DOI":"10.1074\/jbc.275.16.12298","article-title":"Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor","volume":"275","author":"Verrijdt","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajur.2019.09.005_bib63","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1074\/jbc.M009170200","article-title":"Two classes of androgen receptor elements mediate cooperativity through allosteric interactions","volume":"276","author":"Reid","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajur.2019.09.005_bib64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1007024726889","article-title":"Differential regulation of testosterone vs. 5alpha-dihydrotestosterone by selective androgen response elements","volume":"206","author":"Hsiao","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ajur.2019.09.005_bib65","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/humu.22046","article-title":"The androgen receptor gene mutations database: 2012 update","volume":"33","author":"Gottlieb","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ajur.2019.09.005_bib66","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1158\/0008-5472.CAN-16-1616","article-title":"Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancer","volume":"77","author":"Paltoglou","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajur.2019.09.005_bib67","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ccell.2016.04.012","article-title":"TRIM24 is an oncogenic transcriptional activator in prostate cancer","volume":"29","author":"Groner","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajur.2019.09.005_bib68","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1227604","article-title":"EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent","volume":"338","author":"Xu","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ajur.2019.09.005_bib69","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1093\/nar\/gku281","article-title":"The ETS family member GABPalpha modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer","volume":"42","author":"Sharma","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ajur.2019.09.005_bib70","doi-asserted-by":"crossref","first-page":"26321","DOI":"10.1074\/jbc.M203310200","article-title":"Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor","volume":"277","author":"Masiello","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajur.2019.09.005_bib71","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1210\/me.2004-0245","article-title":"Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor","volume":"18","author":"Kang","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajur.2019.09.005_bib72","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0510842103","article-title":"Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells","volume":"103","author":"Baek","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajur.2019.09.005_bib73","first-page":"1970","article-title":"Stepwise androgen receptor dimerization","volume":"125","author":"van Royen","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ajur.2019.09.005_bib74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nature10006","article-title":"Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA","volume":"474","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ajur.2019.09.005_bib75","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1074\/jbc.M113.534859","article-title":"Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif","volume":"289","author":"Jehle","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajur.2019.09.005_bib76","doi-asserted-by":"crossref","first-page":"183","DOI":"10.18632\/oncotarget.449","article-title":"Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor","volume":"3","author":"Guseva","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajur.2019.09.005_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2005.03.007","article-title":"The role of DNA response elements as allosteric modulators of steroid receptor function","volume":"236","author":"Geserick","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajur.2019.09.005_bib78","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.mce.2011.08.012","article-title":"A conserved surface on the ligand binding domain of nuclear receptors for allosteric control","volume":"348","author":"Buzon","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ajur.2019.09.005_bib79","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4103\/1008-682X.183380","article-title":"Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targeting","volume":"18","author":"Kumar","year":"2016","journal-title":"Asian J Androl"},{"key":"10.1016\/j.ajur.2019.09.005_bib80","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.1164265","article-title":"DNA binding site sequence directs glucocorticoid receptor structure and activity","volume":"324","author":"Meijsing","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ajur.2019.09.005_bib81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-2836(02)01355-4","article-title":"Ligands differentially modulate the protein interactions of the human estrogen receptors alpha and beta","volume":"326","author":"Margeat","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1016\/j.ajur.2019.09.005_bib82","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.abb.2011.01.002","article-title":"Genetic variations within the ERE motif modulate plasticity and energetics of binding of DNA to the ERalpha nuclear receptor","volume":"507","author":"Deegan","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ajur.2019.09.005_bib83","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1210\/me.2002-0379","article-title":"Differential modulation of androgen receptor action by deoxyribonucleic acid response elements","volume":"17","author":"Geserick","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajur.2019.09.005_bib84","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1210\/me.2003-0313","article-title":"Differential effect of small ubiquitin-like modifier (SUMO)-ylation of the androgen receptor in the control of cooperativity on selective versus canonical response elements","volume":"18","author":"Callewaert","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ajur.2019.09.005_bib85","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eururo.2016.07.008","article-title":"Intratumoral and intertumoral genomic heterogeneity of multifocal localized prostate cancer impacts molecular classifications and genomic prognosticators","volume":"71","author":"Wei","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajur.2019.09.005_bib86","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1073\/pnas.1304502110","article-title":"Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover","volume":"110","author":"Geng","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajur.2019.09.005_bib87","doi-asserted-by":"crossref","first-page":"370","DOI":"10.23736\/S0393-2249.18.03022-9","article-title":"Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review","volume":"70","author":"Antonelli","year":"2018","journal-title":"Minerva Urol Nefrol"}],"container-title":["Asian Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388219300980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214388219300980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:34:20Z","timestamp":1762000460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214388219300980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2214388219300980"],"URL":"https:\/\/doi.org\/10.1016\/j.ajur.2019.09.005","relation":{},"ISSN":["2214-3882"],"issn-type":[{"value":"2214-3882","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen receptor co-regulation in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajur.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}